AAMU
IMUX icon

Amundi Asset Management US’s Immunic IMUX Stock Holding History

Amundi Asset Management US’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32
Closed -$4K – 1631
2018
Q3 		$4K Hold
32
– – ﹤0.01% 1599
2018
Q2 		$88K Hold
32
– – ﹤0.01% 1472
2018
Q1 		$87K Buy
+32
New +$73.4K ﹤0.01% 1431

Other funds holding IMUX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Amundi Asset Management US's IMUX Position: Q4 2018 in Review

Amundi Asset Management US sold out of Immunic (IMUX) in Q4 2018, closing a stake of 32 shares — an estimated $4K sold.

Amundi Asset Management US first reported a position in IMUX in Q1 2018 and held it in 3 quarters. The position peaked at $88K in Q2 2018. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

  • Amundi Asset Management US reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 32 Immunic shares in Q4 2018, an estimated $4K.
  • Amundi Asset Management US first reported a position in Immunic in Q1 2018 and held it in 3 quarters.
  • Amundi Asset Management US's Immunic position peaked at $88K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on Amundi Asset Management US's 13F filing for Q4 2018, filed 14 Feb 2019.